![PPT - By April Schmidt, RN, BSN Duke University Nurse Anesthesia Program PowerPoint Presentation - ID:2136382 PPT - By April Schmidt, RN, BSN Duke University Nurse Anesthesia Program PowerPoint Presentation - ID:2136382](https://image1.slideserve.com/2136382/argatroban-mechanism-of-action-l.jpg)
PPT - By April Schmidt, RN, BSN Duke University Nurse Anesthesia Program PowerPoint Presentation - ID:2136382
![An overview of mechanism of action of the anticoagulant drugs, showing... | Download Scientific Diagram An overview of mechanism of action of the anticoagulant drugs, showing... | Download Scientific Diagram](https://www.researchgate.net/profile/Guramrinder-Thind/publication/267753112/figure/fig2/AS:601627455148040@1520450571113/An-overview-of-mechanism-of-action-of-the-anticoagulant-drugs-showing-their-effects-on.png)
An overview of mechanism of action of the anticoagulant drugs, showing... | Download Scientific Diagram
![High-dose Argatroban Therapy for Stroke: Novel Treatment for Delayed Treatment and the Recanalization Mechanism - Journal of Stroke and Cerebrovascular Diseases High-dose Argatroban Therapy for Stroke: Novel Treatment for Delayed Treatment and the Recanalization Mechanism - Journal of Stroke and Cerebrovascular Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f8b9838f-72ab-4515-8e3b-79d3398a38c3/gr1_lrg.jpg)
High-dose Argatroban Therapy for Stroke: Novel Treatment for Delayed Treatment and the Recanalization Mechanism - Journal of Stroke and Cerebrovascular Diseases
![Bivalirudin: a direct thrombin inhibitor used during percutaneous coronary intervention | Future Cardiology Bivalirudin: a direct thrombin inhibitor used during percutaneous coronary intervention | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/14796678.1.6.735/asset/images/medium/graphic18.gif)
Bivalirudin: a direct thrombin inhibitor used during percutaneous coronary intervention | Future Cardiology
REBEL EM - Some Anticoagulation Meds I don't typically use in the ED, but am using up in the ICU: Bivalirudin -Half-Life = 25min (with normal renal function) -Mechanism of Action =
![Medicines | Free Full-Text | Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update | HTML Medicines | Free Full-Text | Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update | HTML](https://www.mdpi.com/medicines/medicines-06-00103/article_deploy/html/images/medicines-06-00103-g001-550.jpg)
Medicines | Free Full-Text | Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update | HTML
![PDF] Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia. | Semantic Scholar PDF] Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0a0e10dd1197b466a7125349a5346cc680bcab9a/2-Table1-1.png)
PDF] Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia. | Semantic Scholar
![Bivalirudin resistance in a patient on veno-venous extracorporeal membrane oxygenation with a therapeutic response to argatroban | BMJ Case Reports Bivalirudin resistance in a patient on veno-venous extracorporeal membrane oxygenation with a therapeutic response to argatroban | BMJ Case Reports](https://casereports.bmj.com/content/bmjcr/13/1/e232262/F1.medium.gif)
Bivalirudin resistance in a patient on veno-venous extracorporeal membrane oxygenation with a therapeutic response to argatroban | BMJ Case Reports
![The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite - Journal of Cardiothoracic and Vascular Anesthesia The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite - Journal of Cardiothoracic and Vascular Anesthesia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bf25d44a-379d-462e-a0e8-a99d53aa75b9/gr2_lrg.jpg)
The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite - Journal of Cardiothoracic and Vascular Anesthesia
![Figure 2 | Synthesis and biocompatibility of an argatroban-modified polysulfone membrane that directly inhibits thrombosis | SpringerLink Figure 2 | Synthesis and biocompatibility of an argatroban-modified polysulfone membrane that directly inhibits thrombosis | SpringerLink](https://media.springernature.com/full/springer-static/image/art%3A10.1007%2Fs10856-018-6054-4/MediaObjects/10856_2018_6054_Fig2_HTML.gif)